Stock comparison
AMN Healthcare Services
Genmab A/S
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AMN
AMN Healthcare Services
Market cap
$1.07B
Sector
Healthcare
GMAB
Genmab A/S
Market cap
$16.5B
Sector
Healthcare
Overall winner
Genmab A/S GMAB
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AMN | GMAB | Winner |
|---|---|---|---|
| Warren Buffett | 27F | 65C | GMAB |
| Benjamin Graham | 27F | 64C | GMAB |
| Philip Fisher | 25F | 48D | GMAB |
| Peter Lynch | 17F | 25F | GMAB |
| Joel Greenblatt | 42D | 76B | GMAB |
| Charlie Munger | 20F | 68C | GMAB |
| Terry Smith | 12F | 71C | GMAB |
Side-by-side metrics
| Metric | AMN | GMAB |
|---|---|---|
| Market cap | $1.07B | $16.5B |
| P/E (TTM) | - | 6.2x |
| EV/EBIT | 38.0x | 12.0x |
| ROIC (TTM) | -2.26% | 43.78% |
| Gross margin | 27.63% | 93.88% |
| Net margin | -0.95% | 18.23% |
| Revenue CAGR 5y | -9.01% | -18.45% |
| EPS CAGR 5y | - | -23.48% |
| Debt / Equity | 1.1x | 0.1x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AMN leads on
- P/E (TTM)-vs 6.2x+119%
- Revenue CAGR 5y-9.01%vs -18.45%+51%
GMAB leads on
- Net margin18.23%vs -0.95%+105%
- ROIC (TTM)43.78%vs -2.26%+105%
- Market cap$16.5Bvs $1.07B+93%
- Debt / Equity0.1xvs 1.1x+93%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.